GNF head spent career making scientific discoveries in academia. Read how he now he plans to evolve drug discovery in industry.
As the Ebola outbreak in West Africa continues to expand with isolated cases now being reported in Europe and North America, Novartis and its employees are contributing aid and pursuing research to help fight the deadly virus.
Interview with Mahesh P. Karande, Head of the Africa Cluster for Novartis. In this role, he is responsible for leading Novartis business activities in sub-Saharan Africa.
Drug discovery is field for creative people who want challenges. See why NIBR President Mark Fishman puts patients first in biomedical research.
John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.
By improving access to healthcare in remote areas of developing countries, SMS for Life is making a real difference in the lives of people with malaria and other diseases.
Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.
Don Ganem and his team of infectious disease specialists are working to meet the growing need for new antibiotics, despite major scientific challenges.
This moving personal story about the challenges of living with a rare disease is written by Rocco Falchetto, a biochemist and director of analytical sciences and imaging at the Novartis Institutes for BioMedical Research (NIBR).
Can we learn anything from mice that might help astronauts combat muscle loss in space? Learn how these insights could aid our research of aging:
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.